Abstract��OBJECTIVE To provide reference for introducing new methods and technologies to the physical and chemical testing methods general chapters in Chinese Pharmacopoeia Volume ��. METHODS By reviewing the general chapters of drug physical and chemical testing methods (appendices)in the new editions of European, US, Japanese and British Pharmacopoeias, the harmonization results of the Pharmacopoeia Discussion Group (PDG)and the guidelines of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), the authors summarized the overview and new, revised and harmonized texts of physical and chemical testing methods, and made a preliminary comparison with the related testing methods in Chinese Pharmacopoeia (2015 edition) Volume ��. RESULTS The new and revised text on the physical and chemical testing methods in the new editions of European, US, Japanese and British Pharmacopoeias are mainly concentrated in elements impurities, spectrometry and chemometrics. Chinese Pharmacopoeia can learn from the technology of identification tests, spectrometry and chromatography, impurities analysis and functionality-related characteristics of pharmaceutical excipients. CONCLUSION Chinese Pharmacopoeia should be based on the actual level of China's pharmaceutical industry, follow the principles of progressive and sustainable development, introducing new drug testing technologies and methods to strengthen the quality control of drugs and improve drug controllability.
�����,����,������,��С��. ����ҩ�������鷽��ͨ��(��¼)�ſ�����[J]. �й�ҩѧ��־, 2018, 53(15): 1323-1332.
XU Xin-yi, XU Hua-yu, JIN Gui-min, HONG Xiao-xu. Overview and Analysis of General Chapters (Appendices)of Physical and Chemical Testing Methods in Pharmacopoeias. Chinese Pharmaceutical Journal, 2018, 53(15): 1323-1332.
XIE R, FENG F. Progress on the application of mass spectrometry in pharmacopoeias of different countries[J]. Drug Stand China(�й�ҩƷ��), 2015, 16(5):336-340.
[2]
Ch.P(2015)Vol �� (�й�ҩ��2015���. �IJ�)[S]. 2015.
[3]
EP (9.0)Vol ��[S]. 2016.
[4]
USP (40)Vol ��[S]. 2017.
[5]
JP (17)[S]. 2016.
[6]
BP (2018)Vol ��[S]. 2018.
[7]
BP (2017)Vol ��[S]. 2017.
[8]
USP (39)Vol ��[S]. 2016.
[9]
USP: USP-NF Cumulative List of Revisions Updated?[EB/OL]. [2017-12-29]. http://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-commentary/cumulative_ballot_results.xlsx.
[10]
EDQM: Contents of the 9th Edition[EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/content-list-90.pdf.
[11]
EDQM: Comments concerning revised texts published in the 9th Edition [EB/OL]. [2016-8] https://www.edqm.eu/sites/default/files/supplement-comments-90.pdf.
[12]
EDQM: Contents of Supplement 9.1[EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement-content-list-91.pdf.
[13]
EDQM: Comments concerning revised texts published in Supplement 9.1 [EB/OL]. [2016-10] https://www.edqm.eu/sites/default/files/supplement-comments91.pdf.
[14]
EDQM: Contents of Supplement 9.2 [EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement_pheur-contents_9-2-2016.pdf.
[15]
EDQM: Comments concerning revised texts published in Supplement 9.2 [EB/OL]. [2017-1] https://www.edqm.eu/sites/default/files/supplement-comments-92.pdf.
[16]
EDQM: Contents of Supplement 9.3 [EB/OL]. [2017-8-9] https://www.edqm.eu/sites/default/files/supplement-pheur-contents_9-3-2017.pdf.
[17]
EDQM: Comments concerning revised texts published in Supplement 9.3 [EB/OL]. [2017-6] https://www.edqm.eu/sites/default/files/supplementcomments93_e.pdf.
[18]
JIANG X P, HONG X X. Introduction of general chapters of Chinese Pharmacopoeia 2015 Edition going to the new normal developing [J]. Chin Pharm J(�й�ҩѧ��־), 2015, 50(20):1787-1789.
[19]
QIAN Y L, ZHAO C J, LU A X, et al. X-ray fluorescence spectroscopy and its research progress[J]. Farm Machinery (ũҵ��е), 2011,(16):137-141.
[20]
GAN D L, ZHOU C X. Vibrational circular dichroism: a new tool for the determination of absolute configuration of chiral molecules[J].Chin J Org Chem(�л���ѧ), 2009, 29(6):848-857.
[21]
BURGESS C, HAMMOND J P. Modernisation of the spectroscopic general chapters in the United States Pharmacopeia[J]. Spectrosc Eur, 2015, 27(1):26-29.
[22]
WEI X M, WU Q, LIU Q, et al. Progress on application of chemonetrics-spectrometry in pharmaceutical analysis[J]. Chin J Pharm Anal(ҩ�������־), 2013(8):1447-1452.
[23]
EDQM: New General Chapter on Chemical Imaging in the European Pharmacopoeia[EB/OL]. [2017-1-5]. https://www.edqm.eu/sites/default/files/pressrelease-pheur_new_chapter_chemical_imaging-january2017.pdf.
LI Y, YU Z G, ZHANG J, et al. International certification of API on the elemental impurities[J]. Maschinen Markt(�ִ�����), 2017,(32):16-18.
[26]
JIANG X L, DONG S P, SHU J N. Interpretation of key points of assessment and control of elemental impurities in new drug preparations for ICH Q3D guideline[J]. Chin Pharm Aff(�й�ҩ��), 2017, 31(8):854-860.
[27]
YANG Z, HUANG X F. Recent progress in application of polarization spectrometer[J]. Guangzhou Chem Ind(���ݻ���), 2014, 42(11):44-45.
[28]
CHU D J, JIANG H, HU M. Determination of thimerosal of chondroitin sulfate eye drops in different packing materials by volt-am-pere polarography method[J]. China Pharm(�й�ҩʦ), 2017, 20(2):380-382.
[29]
USP: Harmonization Status for General Chapters [2017-2-28]. http://www.usp.org/harmonized-standards/pdg/general-chapters.
[30]
USP: Harmonization Status for General Methods [2017-2-28]. http://www.usp.org/harmonized-standards/pdg/general-methods.
[31]
ICH Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions.[EB/OL].[2007-11-1]. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q4B/Step4/Q4B_Guideline.pdf.
LIU Y, WANG Z J, DONG X, et al. Application of residual solvents determination method in Chinese Pharmacopoeia 2015 Edition[J]. Chin Pharm J(�й�ҩѧ��־), 2017,52(17):1558-1562.
[34]
LIU Y, WANG Z J, DONG X, et al. Progress in the control concepts and determination methods of residual solvents in pharmaceuticals[J]. Chin New Drug J(�й���ҩ��־), 2017,126(17):2040-2045.
[35]
Chinese Pharmacopoeia Commission.Guidance on Analysis and Testing Technology of the Chinese Pharmacopoeia(�й�ҩ�������⼼��ָ��)[M]. Beijing: China Medical Science Press, 2017: 420-424,487-491.
2018, Vol. 53 
